Standardisation of optical coherence tomography angiography nomenclature in uveitis: first survey results.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
07 2021
Historique:
received: 11 05 2020
accepted: 25 06 2020
revised: 12 06 2020
pubmed: 31 7 2020
medline: 25 9 2021
entrez: 31 7 2020
Statut: ppublish

Résumé

To standardise the nomenclature for reporting optical coherence angiography (OCT-A) findings in the field of uveitis. Members of the International Uveitis Study Group, of the American Uveitis Society and of the Sociedad Panamericana de Infermedades Oculares that choose to participate responded to an online questionnaire about their preferred terminology when reporting on OCT-A findings in uveitis. The response of individuals with several publications on OCT-A (experts) was compared with uveitis specialists (users) who have less than five publications on the field of uveitis and OCT-A. A total of 108 uveitis specialists who participated in the survey were included in the analysis. Of those, 23 were considered OCT-A 'experts'. There was an agreement in both groups for the definition of wide-field (WF)-OCT-A, and definition of neovascularisation in uveitis. Moreover, there was a difference in the responses in other areas, such as quantification of ischaemia, definition of 'large' areas of ischaemia or terms to describe decreased OCT-A signal from different causes. There was an unanimous need of 'users' and 'experts' to distinguish size of decreased OCT-A signal in uveitis, to implement a quantitative measurement of decreased flow specifically for WF-OCT-A and to use different terms for different causes of decreased OCT-A signal. While there was considerable agreement in the terminology used by all uveitis experts, significant differences in terminology were noted between 'users' and 'experts'. These differences indicate the need for standardisation of nomenclature among all uveitis specialists both for the purpose of reporting and in clinical use.

Identifiants

pubmed: 32727731
pii: bjophthalmol-2020-316881
doi: 10.1136/bjophthalmol-2020-316881
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

941-947

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Francesco Pichi (F)

Eye Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates ilmiticopicchio@gmail.com.
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

Ester Carreño Salas (EC)

Ocular Inflammation Unit, Ophthalmology Department, Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain.

Marc D de Smet (M)

Department of Ophthalmology, University of Leiden, Leiden, Netherlands.

Vishali Gupta (V)

Department of Ophthalmology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Manfred Zierhut (M)

Center of Ophthalmology, University of Tuebingen, Tubingen, Germany.

Marion R Munk (MR)

Ophthalmology, Inselspital, University Hospital Bern, Bern, Switzerland.
Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH